The synthesis of retatrutide, a novel dual activator targeting both GLP-1 and GIP receptors, represents a complex several-stage organic process. Early routes focused on protein fragment coupling, utilizing solid-phase creation methodologies to build the long amino acid sequence. Subsequent study has explored various approaches, including enzymatic